Boston Scientific (Natick, Massachusetts) revealed its intent to exercise its option to acquire Cameron Health (San Clemente, California) in a multi-part deal for about $150 million upfront with the potential to grow to $1.3 billion in total payments a move that analysts say could serve as a jolt to the overall ICD market.